Veradigm (NASDAQ:MDRX) Shares Gap Down – Should You Sell?

Veradigm Inc. (NASDAQ:MDRXGet Free Report) gapped down prior to trading on Monday . The stock had previously closed at $4.55, but opened at $4.15. Veradigm shares last traded at $4.75, with a volume of 1,028 shares traded.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Veradigm to a “hold” rating in a research note on Saturday, March 7th.

Get Our Latest Stock Analysis on MDRX

Veradigm Stock Performance

The stock has a market capitalization of $500.94 million, a P/E ratio of 23.25 and a beta of 0.54. The company has a 50-day moving average price of $4.59 and a two-hundred day moving average price of $4.69.

Veradigm Company Profile

(Get Free Report)

Veradigm, Inc (NASDAQ: MDRX) is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company’s offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm’s product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

See Also

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.